In contrast, the CUR pre-treatment represents a promising alternative method of therapy designed to boost the CDDP effect specifically ovarian CDDP- resistance SKOV-3/CDDP cancer cell line through induction apoptosis by down-regulating TRXR1, mTOR/STAT3. The gene discussed is TXNRD1; the disease is cancer.